Abstract 2326: Proteolysis-targeting chimera against NR4A1 for cancer immunotherapy
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-2326
Abstract: Introduction: Modulating tumor-infiltrating immune cells is the key mission for the development of cancer immunotherapy. However, current immunotherapies including immune-checkpoint inhibitors (ICI) have limited patient response rates and some with adverse effects, which drives us… read more here.
Keywords: nr4a1; v04; tumor; cancer ... See more keywords